West Branch Capital LLC Acquires 132 Shares of Colgate-Palmolive (NYSE:CL)

West Branch Capital LLC grew its holdings in shares of Colgate-Palmolive (NYSE:CLFree Report) by 24.0% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 682 shares of the company’s stock after purchasing an additional 132 shares during the quarter. West Branch Capital LLC’s holdings in Colgate-Palmolive were worth $54,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. OFI Invest Asset Management bought a new position in shares of Colgate-Palmolive during the 3rd quarter worth about $25,000. McGlone Suttner Wealth Management Inc. bought a new position in Colgate-Palmolive in the fourth quarter worth approximately $34,000. Quarry LP increased its holdings in shares of Colgate-Palmolive by 48.2% during the second quarter. Quarry LP now owns 446 shares of the company’s stock valued at $34,000 after acquiring an additional 145 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC raised its position in shares of Colgate-Palmolive by 142.0% during the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock worth $35,000 after purchasing an additional 291 shares during the period. Finally, West Tower Group LLC bought a new position in shares of Colgate-Palmolive in the 2nd quarter worth $36,000. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Stock Performance

Shares of CL stock opened at $90.05 on Friday. The company has a debt-to-equity ratio of 8.59, a quick ratio of 0.71 and a current ratio of 1.11. The firm has a market cap of $74.02 billion, a price-to-earnings ratio of 32.39, a P/E/G ratio of 3.43 and a beta of 0.42. Colgate-Palmolive has a 52 week low of $67.62 and a 52 week high of $90.37. The firm’s 50-day simple moving average is $85.90 and its two-hundred day simple moving average is $79.25.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 26th. The company reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.85 by $0.02. Colgate-Palmolive had a net margin of 11.82% and a return on equity of 509.75%. The company had revenue of $4.95 billion for the quarter, compared to analysts’ expectations of $4.89 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. Colgate-Palmolive’s revenue was up 6.9% on a year-over-year basis. As a group, equities analysts forecast that Colgate-Palmolive will post 3.49 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.48. The ex-dividend date is Friday, April 19th. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is presently 69.06%.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Bank of America upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price target for the company in a research note on Friday, December 15th. JPMorgan Chase & Co. raised their price target on shares of Colgate-Palmolive from $88.00 to $90.00 and gave the company an “overweight” rating in a research report on Thursday, January 18th. Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price objective for the company in a research note on Monday, January 29th. StockNews.com downgraded Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a report on Tuesday, February 20th. Finally, Morgan Stanley raised their price objective on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Three equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $87.31.

Read Our Latest Stock Analysis on Colgate-Palmolive

Insider Buying and Selling

In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the stock in a transaction dated Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the completion of the transaction, the director now owns 19,272 shares in the company, valued at $1,628,484. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Colgate-Palmolive news, Director C Martin Harris sold 2,760 shares of the business’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $84.50, for a total transaction of $233,220.00. Following the sale, the director now owns 19,272 shares of the company’s stock, valued at approximately $1,628,484. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The disclosure for this sale can be found here. In the last 90 days, insiders sold 232,371 shares of company stock valued at $19,505,099. 0.34% of the stock is owned by insiders.

About Colgate-Palmolive

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.